Physician
Taheri, Sean
Taheri, Sean was paid $103K by Medicaid between Dec 2019 and Nov 2024, across 9 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.
33Billing provider infoTAHERI, SEAN
HOOPESTON, IL 60942
HOOPESTON, IL 60942
33aNPI1346668217assigned 03/28/2014
33bProvider typeFamily Medicine Physician
28Total paid$103K
24GClaims2,549
24DCodes billed9
24AFirst – last monthDec 2019 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#949 of 2,947
Median peer was paid$43K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 12 | $484.19 | |
| 2020 | 356 | $15K | |
| 2021 | 599 | $28K | |
| 2022 | 488 | $17K | |
| 2023 | 899 | $33K | |
| 2024incomplete | 195 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56% | 1,548 | 1,502 | $57K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 18% | 412 | 354 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 16% | 319 | 274 | $16K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.8% | 94 | 90 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.2% | 43 | 29 | $4K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 18 | 16 | $646.38 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 16 | 13 | $617.40 |
| 99072 | 0% | 23 | 14 | $0.00 | |
| 99051 | 0% | 76 | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.